Discovery and SAR of 5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic Acid (CX-4945), the First Clinical Stage Inhibitor of Protein Kinase CK2 for the Treatment of Cancer.
| Autor: | Fabrice Pierre, Peter C. Chua, Sean E. O’Brien, Adam Siddiqui-Jain, Pauline Bourbon, Mustapha Haddach, Jerome Michaux, Johnny Nagasawa, Michael K. Schwaebe, Eric Stefan, Anne Vialettes, Jeffrey P. Whitten, Ta Kung Chen, Levan Darjania, Ryan Stansfield, Kenna Anderes, Josh Bliesath, Denis Drygin, Caroline Ho, May Omori |
|---|---|
| Zdroj: | Journal of Medicinal Chemistry; Jan2011, Vol. 54 Issue 2, p635-654, 20p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|